Interesting analysis -additonal evidence supporting what has now become the standard practice in the oncology community. – Patricia Ford
This helpful article offers increased understanding and ability to utilize the functional assessment of cancer therapy (FACT) scale. – Patricia Ford
An exciting issue is studied in this head/neck cancer patient population. Perioperative EPO may have a role to decrease blood transfusion needs and speed recovery.
This is an editorial on an article we commented previously (Gannon et al. Crit Care Med 2002;30:1893-5). The author reviews a number of interesting points
This is a good review of cancer- and chemotherapy-related anemia and its treatment with epoetin alfa. However, the review seems a bit negative regarding epoetin
Published this month in Blood and the Journal of Clinical Oncology are the much discussed and debated guidelines of a blue ribbon panel on the
Somewhat similar to the letter published by Cothren et al. in the NEJM, this article reports the case of a Jehovah’s witness who bled to
This is a very important study as it has long been debated whether relevant amounts of free iron circulate after the administration of parenteral iron.
The authors from Taiwan state that they used “Ferrum Hausmann, a ferric polymaltose complex.” Under the same name (Ferrum Hausmann), iron saccharate (identical to iron
The article confirms the data of Carson et al, Lancet 1988, that perioperative anemia is a significant risk factor. However, the belief that transfusion may
It is well known that Ferritin and Transf.sat are parameters that are influenced by various factors such as inflammation, iron overload, varying serum iron levels,
This is a most valuable study concerning the use of rHuEPO and iron sucrose in predialysis patients. While it is quite predictable that rHuEPO and
It is certainly of great value to have an overview about different iron regimens in combination with rHuEPO. However, at least in Europe, there is